{"changeSha256":"b58accfb6d40670004761eff08f068f1b9cb8d4cc822d1480dbb5a844191cc1d","changedAt":"2026-11-16","changedFields":[{"after":"The only human study found is a small 2015 Russian study of selank added to phenazepam in anxiety disorders, checkable only from its abstract; the other published work cited here is in rats. No FDA approval is reported, and selank is not among the six peptides in HHS’s October 2026 draft enforcement-discretion policy.","before":"No human study is cited in the reviewed sources; the published work cited here is in rats. No FDA approval is reported, and selank is not among the six peptides in HHS’s October 2026 draft enforcement-discretion policy.","field":"Evidence note"},{"after":"fda-selank-identity, journal-pmid-28280289, fda-bulk-peptide-risks, hhs-503a-peptide-enforcement-discretion-notice-2026, hhs-503a-peptide-enforcement-discretion-policy-2026, journal-pmid-26356395","before":"fda-selank-identity, journal-pmid-28280289, fda-bulk-peptide-risks, hhs-503a-peptide-enforcement-discretion-notice-2026, hhs-503a-peptide-enforcement-discretion-policy-2026","field":"Cited source records"},{"after":"name: fda-selank-identity, fda-bulk-peptide-risks; aliases: fda-bulk-peptide-risks; category: fda-bulk-peptide-risks; status: fda-bulk-peptide-risks; summary: fda-selank-identity, fda-bulk-peptide-risks; evidenceNote: journal-pmid-26356395, journal-pmid-28280289, fda-bulk-peptide-risks, hhs-503a-peptide-enforcement-discretion-policy-2026","before":"name: fda-selank-identity, fda-bulk-peptide-risks; aliases: fda-bulk-peptide-risks; category: fda-bulk-peptide-risks; status: fda-bulk-peptide-risks; summary: fda-selank-identity, fda-bulk-peptide-risks; evidenceNote: journal-pmid-28280289, fda-bulk-peptide-risks, hhs-503a-peptide-enforcement-discretion-policy-2026","field":"Claim citations"}],"currentVersion":{"canonicalUrl":"https://peptidescanner.com/peptides/selank/versions/2/","version":2},"id":"profile:selank:v2","interpretationBoundary":"This event describes a PeptideScanner public-version change. It does not by itself establish that the cited source changed, that a scientific conclusion changed, or that source monitoring is continuous.","kind":"profile-updated","notice":"We added a 2015 Russian clinical study of selank added to phenazepam in patients with anxiety disorders. Earlier versions said no human study was cited among the sources reviewed.","peptideSlugs":["selank"],"previousChangeEvent":null,"previousVersion":{"canonicalUrl":"https://peptidescanner.com/peptides/selank/versions/1/","version":1},"schemaVersion":"peptidescanner-public-correction-lineage-event/v1","sourceRecords":[{"id":"journal-pmid-26356395","name":"Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova","sourceClass":"A","title":"Optimization of the treatment of anxiety disorders with selank (2015, in Russian) · PMID 26356395","url":"https://doi.org/10.17116/jnevro20151156133-40","verifiedAt":"2026-11-16"}],"subject":{"slug":"selank","type":"profile"}}
